ABSTRACT
Intracranial hypertension [IH] is one of the final pathways of acute brain injury. In severe traumatic brain injury [sTBI], it independently predicts poor outcomes. Its control represents a key aspect of the management. Lack of response to conventional therapies signals a state of ''refractory IH'', with an associated mortality rate of 80-100%. In such cases, hypothermia, barbiturates at high doses [BBT], decompressive craniectomy [DC], and extreme hyperventilation are utilized. However, none of them has proven efficacy. Indomethacin [INDO], a non-steroidal anti-inflammatory drug, may be an option with an acceptable safety profile and easy to administer. Reported series showed encouraging results. We herein present a case of refractory IH after sTBI in which INDO was utilized. In refractory IH, INDO can help to decrease ICP and improve cerebral perfusion pressure. However, it requires administration under strict protocol since it's not free of adverse effects after withdrawal